SCHEMBL6679893

SCHEMBL6679893

[CH2]Cc1csc(NC(=O)OC(C)(C)C)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT1 Q96EB6 1/20 0.49
PI4KB Q9UBF8 1/20 0.46
SMN1; SMN2 Q16637 5/20 0.46
KMT2A Q03164 1/20 0.46
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
HDAC3 O15379 2/20 0.41
HDAC1 Q13547 2/20 0.41
HDAC2 Q92769 2/20 0.41
HDAC10 Q969S8 2/20 0.41
HDAC8 Q9BY41 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
CCR2 P41597 2/20 0.41
ALDH1A1 P00352 2/20 0.41
LMNA P02545 1/20 0.41
KCNH2 Q12809 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2175797 0.87 SMN1; SMN2 (0.50) SIRT1PI4KBSMN1; SMN2KMT2ATSHR
SCHEMBL1030124 0.87 PI4KB (0.50) SIRT1PI4KBSMN1; SMN2KMT2ATSHR
SCHEMBL16123390 0.86 SIRT1 (0.52) SIRT1PI4KBSMN1; SMN2KMT2ATSHR
SCHEMBL356279 0.86 SMN1; SMN2 (0.64) SIRT1PI4KBSMN1; SMN2KMT2ATSHR
SCHEMBL13033265 0.86 SIRT1 (0.49) SIRT1PI4KBSMN1; SMN2KMT2ATSHR
SCHEMBL9071272 0.86 SIRT1 (0.49) SIRT1PI4KBSMN1; SMN2KMT2ATSHR
SCHEMBL299175 0.84 SMN1; SMN2 (0.51) SIRT1PI4KBSMN1; SMN2KMT2ATSHR
SCHEMBL12742401 0.84 PTPRB (0.49) SIRT1PI4KBSMN1; SMN2KMT2ATSHR
SCHEMBL21228025 0.84 SIRT1 (0.48) SIRT1PI4KBSMN1; SMN2KMT2ATSHR
SCHEMBL944485 0.84 PI4KB (0.51) SIRT1PI4KBSMN1; SMN2KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102083438-A Quenolines and related analogs as sirtuin modulators SIRTRIS PHARMACEUTICALS INC 2011-06-01 CN disclosed
EP-1472226-A1 HETEROCYCLIC AMIDE COMPOUNDS AS APOLIPOPROTEIN B INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-11-03 EP disclosed
WO-2004039795-A2 AMIDE COMPOUNDS FOR THE TREATMENT OF HYPERLIPIDEMIA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-05-13 WO disclosed
CN-1478077-A Benzamide compounds as APO B secretion inhibitors ����ҩƷ��ҵ��ʽ���� 2004-02-25 CN disclosed
EP-1326835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-16 EP disclosed
WO-2003045921-A1 HETEROCYCLIC AMIDE COMPOUNDS AS APOLIPOPROTEIN B INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-06-05 WO disclosed
WO-2002028835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-04-11 WO disclosed